Cargando…
The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
The Coronavirus outbreak globally has changed the medical system and also led to a shortage of medical facilities in both developing and underdeveloped countries. The COVID19 disease, being novel in nature along with high infectivity and frequent mutational rate, has been termed to be fatal across t...
Autores principales: | Ghosh, Asmita, Sarkar, Anusua, Paul, Pubali, Patel, Parth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Mycological Society. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445778/ https://www.ncbi.nlm.nih.gov/pubmed/34548877 http://dx.doi.org/10.1016/j.fbr.2021.09.003 |
Ejemplares similares
-
From black to white: A roadmap to containing the rise of candidiasis amidst COVID-19 and mucormycosis in India
por: Nawaz, Faisal A., et al.
Publicado: (2021) -
Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
por: León-Buitimea, Angel, et al.
Publicado: (2021) -
Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
por: Raut, Akshay, et al.
Publicado: (2021) -
Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021) -
Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)